FDA approves a second vaccine to prevent serogroup B meningococcal disease
The U.S. Food and Drug Administration has approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of… …read more